- Home
- MGRM vs SCPH Comparison
MGRM vs SCPH Comparison
Compare MGRM & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRM
- SCPH
- Stock Information
- Founded
- MGRM 2016
- SCPH 2013
- Country
- MGRM United States
- SCPH United States
- Employees
- MGRM N/A
- SCPH N/A
- Industry
- MGRM Medical/Dental Instruments
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- MGRM Health Care
- SCPH Health Care
- Exchange
- MGRM Nasdaq
- SCPH Nasdaq
- Market Cap
- MGRM 195.3M
- SCPH 173.6M
- IPO Year
- MGRM N/A
- SCPH 2017
- Fundamental
- Price
- MGRM $5.35
- SCPH $4.78
- Analyst Decision
- MGRM Strong Buy
- SCPH Strong Buy
- Analyst Count
- MGRM 1
- SCPH 3
- Target Price
- MGRM $5.40
- SCPH $14.00
- AVG Volume (30 Days)
- MGRM 225.3K
- SCPH 361.3K
- Earning Date
- MGRM 08-18-2025
- SCPH 08-07-2025
- Dividend Yield
- MGRM N/A
- SCPH N/A
- EPS Growth
- MGRM N/A
- SCPH N/A
- EPS
- MGRM N/A
- SCPH N/A
- Revenue
- MGRM N/A
- SCPH $49,969,000.00
- Revenue This Year
- MGRM N/A
- SCPH $108.95
- Revenue Next Year
- MGRM N/A
- SCPH $73.83
- P/E Ratio
- MGRM N/A
- SCPH N/A
- Revenue Growth
- MGRM N/A
- SCPH 107.79
- 52 Week Low
- MGRM $1.92
- SCPH $1.94
- 52 Week High
- MGRM $6.02
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- MGRM 63.65
- SCPH 48.08
- Support Level
- MGRM $5.29
- SCPH $4.13
- Resistance Level
- MGRM $5.53
- SCPH $4.96
- Average True Range (ATR)
- MGRM 0.12
- SCPH 0.35
- MACD
- MGRM -0.13
- SCPH -0.12
- Stochastic Oscillator
- MGRM 23.08
- SCPH 37.90
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.